Table 1.
Laboratory parameters during admission and follow-up
| Laboratory parameters | Day 1 | Day 4 | Day 30 |
|---|---|---|---|
| Hemoglobin, g/dL | 15 | 14.2 | 14.6 |
| Hematocrit, % | 46 | 45 | 45.2 |
| Leukocytes, 103 mL | 17 | 10.6 | 9.4 |
| Neutrophils, % | 85 | 72 | 72 |
| Lymphocytes, % | 9 | 23 | 22 |
| Platelets, 103 mL | 171 | 220 | 264 |
| Blood urea nitrogen, mg/dL | 8 | 10 | 10 |
| Serum creatinine, mg/dL | 0.54 | 0.7 | 0.8 |
| Serum sodium, mmol/L | 135 | 137 | |
| Serum potassium, mmol/L | 3.8 | 3.7 | |
| Serum calcium, mg/dL | 8.5 | 8.7 | |
| Serum phosphate, mg/dL | 2.8 | ||
| Serum magnesium, mg/dL | 1.9 | ||
| C-reactive protein, mg/mL | 4.64 | 1.02 | 0.5 |
| LDH, U/L | 236 | 210 | 196 |
| Total bilirubin, mg/dL | 0.9 | 0.9 | 0.9 |
| Direct bilirubin, mg/dL | 0.3 | 0.3 | 0.3 |
| ALT, U/L | 9 | 11 | 15 |
| AST, U/L | 21 | 24 | 22 |
| ALP, U/L | 112 | 120 | 108 |
| GGT, U/L | 12 | 14 | 16 |
| Serum protein, g/dL | 6.7 | 6.9 | 7 |
| Serum albumin, g/dL | 3.5 | 3.7 | 3.8 |
| Serum amylase, U/L | 836 | 76 | 62 |
| Serum lipase, U/L | 4376 | 68 | 40 |
| Total cholesterol, mg/dL | 188 | ||
| Serum triglycerides, mg/dL | 140 | ||
| LDL cholesterol, mg/dL | 132 | ||
| ANA | Negative | ||
| rRT-PCR SARS-CoV-2 | Negative | ||
| HBsAg | Negative | ||
| Anti HCV | Negative | ||
| HIV antibodies | Negative | ||
| Urine routine | No proteins. No pus cells/RBCs |
LDH lactate dehydrogenase, ALT alanine transaminase, AST aspartate transaminase, ALP alkaline phosphatase, GGT gamma-glutamyl transpeptidase, LDL low density lipoprotein, ANA antinuclear antibody, rRT-PCR real-time reverse transcriptase polymerase chain reaction, SARS-CoV-2 severe acute respiratory syndrome coronavirus 2, HBsAg hepatitis B surface antigen, Anti-HCV anti-hepatitis C antibody, HIV human immunodeficiency virus